Dozic Forte

Quick links to important sections

Dozic Forte

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dozic Forte

Quick Facts

Property Description
Active ingredients Diclofenac and Paracetamol (Acetaminophen)
Form Solid oral dosage form (Tablet)
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID) and Analgesic
Common use Symptomatic relief of pain, inflammation, and fever
Origin Synthetic

What Type of Medicine is Dozic Forte?

Dozic Forte is classified as a fixed-dose combination product, containing two distinct active pharmaceutical ingredients that assign it to two primary pharmacological classes: an Analgesic (pain reliever) and a Non-Steroidal Anti-Inflammatory Drug (NSAID). The medicine is of synthetic origin and is supplied as a solid oral dosage form intended for oral administration. The combination format is structured to deliver multiple therapeutic effects from a single tablet, an approach intended for managing symptoms that are complex or require dual-pathway intervention.

Composition and Dual-Action Formulation

The medicine’s core functionality is derived from its two active ingredients [INN]: Diclofenac and Paracetamol (Acetaminophen). Diclofenac primarily provides the potent anti-inflammatory properties, while Paracetamol contributes the primary analgesic and antipyretic (fever-reducing) effects. Diclofenac is used to decrease inflammation and pain, while Paracetamol is used for relieving mild to moderate pain. This dual-action design ensures that both the localized tissue inflammation and the body’s centralized response to pain and temperature are addressed simultaneously.

General Therapeutic Purpose

The general therapeutic purpose of Dozic Forte is to achieve comprehensive, symptomatic relief when discomfort is accompanied by multiple symptoms, such as the pain and swelling characteristic of musculoskeletal conditions. The preparation is utilized to leverage the synergistic benefit of its components. Combining an NSAID with an analgesic like Paracetamol can lead to better overall relief than either agent used alone. The outcome is a powerful symptomatic triad: a reduction in localized inflammation and swelling, relief from general pain, and the lowering of an elevated body fever.

Regulatory References

  1. MedlinePlus

What side effects are possible with Dozic Forte?

Possible side effects and safety information

The official safety profile for Dozic Forte, a combination of Diclofenac (an NSAID) and Paracetamol, is defined by regulatory agencies based on the known risks of its active components. Adverse reactions are formally classified by frequency and grouped into major System-Organ Classes (SOCs), which include Gastrointestinal Disorders, Hepatobiliary Disorders, Cardiac Disorders, and Nervous System Disorders.

Adverse reactions classified as common in regulatory documents typically include gastrointestinal issues such as dyspepsia, nausea, and abdominal pain, along with nervous system effects like headache and dizziness.

Serious Adverse Reactions

Official labels document the potential for serious, though less frequent, adverse events. These include life-threatening gastrointestinal bleeding, ulceration, or perforation; an increased risk of serious cardiovascular thrombotic events (such as myocardial infarction and stroke), which may occur early in treatment; and the potential for severe liver injury (hepatotoxicity), a major concern associated with Paracetamol.

Safety Context and Special Populations

Safety statements note that the risk of serious gastrointestinal events increases with the duration of use, while the risk of cardiovascular events is considered dose-dependent. Furthermore, regulatory documents specify heightened safety considerations for certain groups: older adults have an increased risk of serious gastrointestinal events, and patients with pre-existing cardiovascular disease or impaired hepatic or renal function require particular caution. The medicine is contraindicated in specific high-risk situations, such as perioperative pain in the setting of coronary artery bypass graft (CABG) surgery.

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information

The official regulatory profile for an overdose emphasizes the combined risks of severe liver damage from the Paracetamol component and acute gastrointestinal effects from the Diclofenac component.

Feature Official Regulatory Statement
Documented Manifestations Early symptoms (within 24 hours) may include nausea, vomiting, pallor, and abdominal pain. Delayed signs may include laboratory evidence of liver toxicity, sometimes preceded by dizziness or drowsiness from the Diclofenac component.
Severe Outcomes Overdose can lead to hepatic necrosis, acute liver failure, acute renal failure, coma, and death. Severe gastrointestinal bleeding or seizures are documented risks in very severe overdose.
Population-Specific Risk The hazard of toxicity is officially documented as greater in those with non-cirrhotic alcoholic liver disease or conditions of glutathione depletion (e.g., severe malnutrition or sepsis).

Mandatory Emergency Actions

Immediate medical advice must be sought in the event of an overdose, even if the person feels well, because of the risk of delayed, serious liver damage. Patients must be referred to the hospital urgently for immediate medical attention. The effective antidote, N-acetylcysteine (NAC), is available, but its efficacy is substantially higher when administered within the first 8 hours post-ingestion, which dictates the urgency of seeking help. Supportive care, fluid support, and procedures like activated charcoal (if taken within one hour) and blood monitoring for liver enzymes are officially described management steps.

Therapeutic Uses of Dozic Forte

What Dozic Forte treats: main uses and benefits

This combination medication is primarily used to address symptoms related to inflammatory and pain conditions, particularly those involving the musculoskeletal system. It is applied across domains where the pain is linked to localized tissue inflammation and swelling, and is relevant for easing the symptoms related to stiffness associated with chronic disorders such as osteoarthritis and rheumatoid arthritis. It is also commonly used for relief in acute scenarios, including discomfort from soft tissue injuries like sprains and strains, post-procedural pain following dental work, and recurrent, episodic syndromes such as tension headaches and painful menses (dysmenorrhea).

The combination is applied in addressing the systemic symptom cluster of pain, inflammation, and elevated body temperature (fever). The goal of its use is purely symptomatic: “It provides supportive therapeutic benefit by helping to ease the overall burden of distressing manifestations and assists patients in coping more steadily with difficult episodes.” Using it during periods of symptom intensification generally contributes to improved comfort during these periods.

Quick Fact: Relief for Pain, Inflammation, and Fever
Primary Therapeutic Area Musculoskeletal pain and acute inflammatory episodes.
Conditions Osteoarthritis, rheumatoid arthritis, sprains/strains, dental pain.
Key Benefit Supportive relief for multiple symptom axes.

Regulatory References

  1. NIH StatPearls overview of Diclofenac's uses

Eligibility and Restrictions for Use

This section explains the official population eligibility and non-eligibility rules for Dozic Forte, a combination of Diclofenac and Paracetamol, as defined by regulatory bodies.


Contraindicated Populations

Use of this medicine is formally prohibited for certain groups based on its active components:

  • Patients with known hypersensitivity to Diclofenac, Paracetamol, or any NSAID (such as aspirin) that has previously caused asthma, hives, or allergic-type reactions.
  • Individuals with active gastrointestinal ulceration, GI hemorrhage, or perforation.
  • Patients with severe hepatic or severe renal insufficiency.
  • Those in the setting of Coronary Artery Bypass Graft (CABG) surgery.
  • Patients with established congestive heart failure (NYHA II–IV), ischemic heart disease, or cerebrovascular disease (based on Diclofenac warnings).

Age and Developmental Status

  • Pediatric Use: The product is contraindicated for use in children less than 15 years of age in some official regulatory labels.
  • Pregnancy: It is contraindicated during the second and third trimesters of pregnancy.
  • Lactation: Use is generally not recommended or is contraindicated while breastfeeding.
  • Older Adults: Caution is formally required due to an increased risk of serious adverse events (GI, cardiac, renal).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information describes several categories of medically significant interactions for this product, primarily involving pharmacodynamic effects that increase the risk of specific adverse events and pharmacokinetic changes that alter drug levels in the body.

Interacting Product Categories and Constraints:

  • Other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Aspirin: Co-administration with other NSAIDs or non-low-dose aspirin is generally not recommended due to an increased risk of serious gastrointestinal complications.
  • Anticoagulants and Antiplatelet Agents: Concomitant use with agents like Warfarin requires close monitoring for signs of bleeding due to a heightened pharmacodynamic effect on hemostasis.
  • Antihypertensives and Diuretics: The drug may reduce the therapeutic effect of certain blood pressure medications (e.g., ACE Inhibitors, ARBs, Diuretics). In high-risk populations, such as elderly patients or those with impaired renal function, combined use requires specific monitoring of renal function and blood pressure.
  • Immunosuppressants: Co-administration with certain agents (e.g., Methotrexate) may elevate their plasma concentrations, potentially leading to increased toxicity and requiring high-level patient monitoring.

Product-Specific Interactions:

  • Alcohol: Consumption of alcohol may increase the risk of gastrointestinal bleeding associated with this medicine.

Mechanism of Action

How Dozic Forte Works: A Dual-Action Mechanism

The combination mechanism involves modulation across two distinct physiological areas: peripheral tissues and central processing centers for nociception and thermoregulation.


Peripheral Enzyme Inhibition

This domain covers Diclofenac's interaction with the Cyclooxygenase ( COX) enzyme system, primarily COX-2. By inhibiting these enzymes, the medicine limits the synthesis of Prostaglandins, which are chemical mediators responsible for sensitizing peripheral nerve endings and initiating inflammatory signaling. This molecular intervention limits the generation of Prostaglandins and associated chemical mediators at the tissue level.


Central Pain and Thermoregulatory Modulation

This domain is defined by Paracetamol's action within the Central Nervous System ( CNS) and spinal cord. Its mechanism involves influencing central COX isoforms and utilizing its metabolite to modulate neuronal receptors, notably the TRPV1 channels and the CB1 system. This targeted central modulation results in the potentiation of the body's descending pain inhibitory pathways, and concurrently, the inhibition of Prostaglandin E2 ( PGE2) in the hypothalamus adjusts the elevated thermoregulatory set-point.

Dosage and Administration Information

Official Administration Guidelines for Dozic Forte

Dozic Forte is a fixed-dose combination tablet containing Diclofenac 50 mg and Paracetamol 500 mg. The established principles for its use ensure proper administration, focusing on the standard oral route and precise dosing limits.


Instruction Detail
Route of Administration The medicine is administered orally as a solid tablet.
Dosing Schedule Standard adult dosing is typically one tablet taken two to three times per day. The total daily dosage must not exceed three tablets.
Timing in Relation to Meals Tablets should be taken with or immediately after food or a meal.
Special Procedural Conditions The tablet must be swallowed whole with liquid; it must not be crushed, chewed, or split.

Procedural Structure and Administration Rules

  • Use the lowest effective dose for the shortest duration necessary to control symptoms.
  • Doses should be taken at regular, spaced intervals throughout the day.
  • If a dose is missed, the patient should skip the missed dose and take the next dose at the regularly scheduled time. Do not double the dose.
  • Older Adults (Elderly): The lowest effective dosage should be used, particularly in frail patients.

This instruction set establishes the standard clinical protocol for using this combination medicine. The strict dosing and integrity requirements for the tablet ensure the medicine is administered as intended.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research examined the findings of studies involving the drug, which is investigated for use in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) who meet specific criteria.

Clinical Trials Summary

Overall Survival (OS) and Progression-Free Survival (PFS)

  • Phase 3 trials reported findings related to overall survival (OS) when the drug was used in combination with standard chemotherapy.
  • Studies have evaluated the effect of the drug on tumor size and spread. The primary endpoints in pivotal studies included OS and progression-free survival (PFS).
  • A meta-analysis evaluated five-year survival rates among participants using the drug in addition to a standard regimen compared to the standard regimen alone.

Safety and Adverse Events (AEs)

  • Cardiovascular issues, including hypertension, were observed as common and serious events in studies. Monitoring participants for these events was part of the study protocols.
  • Commonly reported adverse events in trials also included fatigue, nausea, and changes in liver enzyme levels.
  • Studies examined whether these adverse events were generally manageable through protocols or standard supportive care.

Quality of Life and Symptom Management

Additional studies also explored whether the drug influenced the self-reported symptoms of pain and fatigue associated with advanced cancer. Evidence remains limited regarding the comprehensive long-term impact on overall patient quality of life. Research has compared findings from this drug to those from older treatment methods. It is not yet clear whether the long-term benefit-risk profile differs substantially across patient subpopulations.

Frequently Asked Questions (FAQ)

Common questions about Dozic Forte (FAQ)

Q: How quickly does it usually take to feel the full effects of Dozic Forte?

A: According to official product information, the paracetamol component is known to have an early onset of action, which helps with initial pain relief. However, the full anti-inflammatory and analgesic efficacy of the combined medication may require a few hours for the full anti-inflammatory action to be experienced.

Q: Are there any specific warning signs mentioned in official documents when starting Dozic Forte?

A: Regulatory documents list signs that patients should be aware of regarding serious adverse events. These include symptoms of gastrointestinal bleeding (such as black or tarry stools), liver injury (like yellowing of the skin or eyes), and signs of a cardiovascular event (such as sudden weakness or slurred speech).

Q: Does Dozic Forte need to be taken at the exact same time every day to work properly?

A: Official administration guidelines indicate that doses should be taken at regular, spaced intervals throughout the day. This schedule helps maintain consistent drug levels, which is necessary for achieving the intended therapeutic benefit.

Q: What does the research evidence say about the long-term safety profile of Dozic Forte?

A: Studies and official information indicate that long-term use of this combination medicine is associated with an increased risk of serious adverse events. These risks include gastrointestinal bleeding, cardiovascular thrombotic events (like heart attack or stroke), and renal toxicity.

Q: Are there any official studies examining new uses for Dozic Forte?

A: Clinical trial summaries included in the regulatory files detail research examining the use of the medicine in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) in combination with standard regimens.

Q: What is the process for safely disposing of unused or expired Dozic Forte?

A: Governmental agencies recommend disposing of unused medicine through an authorized drug take-back program or a drop-off site. In the absence of a take-back program, official guidance describes a method of at-home disposal that involves mixing the medicine with an undesirable substance, such as coffee grounds or dirt, sealing it in a container, and placing it in household trash.

Q: Does taking Dozic Forte require special monitoring or blood tests?

A: Official product information notes that specific monitoring may be required, particularly for high-risk patient groups, such as older adults or those with pre-existing conditions. This includes close monitoring of blood pressure, kidney function, and liver enzyme levels.

Q: What should I know about taking Dozic Forte if I have an upcoming surgery?

A: Regulatory documents state that the medicine is strictly contraindicated for pain management in the setting of Coronary Artery Bypass Graft (CABG) surgery. Due to the associated risk of bleeding, it is important to discuss any planned surgery with a healthcare provider.

Q: What is the general expectation for improvement when starting Dozic Forte?

A: The medicine is intended to provide symptomatic relief that often begins rapidly due to the paracetamol component. The full anti-inflammatory and analgesic effect is expected to be achieved as the diclofenac component reaches its full efficacy over a few hours.

Q: How long does Dozic Forte stay in your system after the last dose?

A: Official regulatory documents contain pharmacokinetic (PK) data that defines the elimination half-life for the active components. This data is used by healthcare professionals to estimate the time required for the medicine to be significantly reduced in the body.

Q: Does Dozic Forte affect weight or appetite?

A: Regulatory documents list loss of appetite and unexplained weight gain as possible symptoms that may be associated with certain serious adverse reactions, particularly those affecting the liver or kidneys.

Q: Is hair loss a known possible effect of Dozic Forte?

A: Loss or thinning of the hair has been reported as a less common side effect associated with one of the active components of this medicine.

Q: Does Dozic Forte affect sleep patterns?

A: Official product information lists possible side effects associated with the medicine, which include sleepiness or unusual drowsiness, and, in some cases, trouble sleeping (insomnia).

Q: What should I expect when stopping Dozic Forte as described in regulatory information?

A: Regulatory guidance states that the medicine can typically be discontinued once symptoms are relieved if used for short-term conditions. Abrupt cessation of the medicine may result in the return of symptoms for which the drug was originally prescribed.

Q: Can I take Dozic Forte with standard vitamins or common herbal supplements?

A: Official documents list potential interactions with certain dietary supplements, such as Vitamin E and glucosamine, which may affect bleeding risk or drug clearance. It is important that any supplements being taken are disclosed to a healthcare provider for review.

Q: What foods are officially mentioned as potentially interacting with Dozic Forte?

A: No specific foods are formally listed in regulatory documents as interacting with this medicine. However, administration guidelines recommend taking the tablet with or immediately after food to reduce the potential for gastrointestinal irritation.

Q: Is it safe to drink caffeine or coffee while taking Dozic Forte?

A: Official regulatory information does not list caffeine as a specific contraindication or interaction. The paracetamol component, however, is metabolized by liver enzymes that may be affected by substances like caffeine.

Q: Is Dozic Forte known to be habit-forming or addictive?

A: The active component Diclofenac is not known to be habit-forming. While the medicine is not considered addictive in the same way as controlled substances, long-term use of the paracetamol component may be associated with psychological dependence in rare cases.

Q: Is it correct that Dozic Forte has a Black Box Warning or similar regulatory caution?

A: Yes, as an NSAID-containing product, this medicine is required to carry a Boxed Warning regarding serious, sometimes fatal, cardiovascular thrombotic events and serious gastrointestinal adverse events. There is also an important warning for potential liver injury (hepatotoxicity).

Q: Can Dozic Forte affect driving or operating machinery?

A: Regulatory information notes that the medicine may cause side effects such as dizziness, drowsiness, or visual disturbances. If these effects occur, official warnings state that operating vehicles or machinery should be avoided.

Q: Is Dozic Forte a controlled substance or scheduled drug?

A: The medicine is not classified as a controlled substance or scheduled drug under US federal regulations. This status is documented in the official labeling.

Q: Does the package insert for Dozic Forte recommend against exposure to sunlight?

A: Increased sensitivity of the skin to sunlight has been reported as a side effect associated with the diclofenac component. This may necessitate the use of caution concerning unnecessary sun exposure.

How should Dozic Forte be stored and disposed of?

How to Store and Dispose of Dozic Forte?

Official regulatory documents define specific conditions to maintain the stability and integrity of Dozic Forte suppositories. The storage profile is strictly based on the manufacturer’s authorized labeling.

Official Storage and Handling Requirements

Requirement Type Official Statement
Maximum Temperature Do not store above 25 C.
Packaging Protection Store in the original package.
Shelf Life 2 years (unopened).
Handling Note Remove the suppository from the blister packaging only immediately before use.
Child Safety Keep out of the reach and sight of children.

Disposal

The product labeling requires that the medicine be disposed of according to local regulatory precautions. No specific, product-unique instructions for final disposal or environmental hazardous-waste handling are detailed in the official product information.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Dozic Forte found in:

A-Z Index: